FDA to launch study on drugs' effects on pregnancy

12/30/2009 | Reuters

The FDA has announced a research collaboration that will focus on the safety of drugs given to pregnant women. The Medication Exposure in Pregnancy Risk Evaluation Program was prompted by concerns about insufficient clinical trials on the issue at a time when two-thirds of women reportedly take at least one prescription drug during pregnancy.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA